Repligen
RGEN
#2045
Rank
HK$72.29 B
Marketcap
HK$1,284
Share price
-0.47%
Change (1 day)
15.97%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : HK$22.75 Billion

According to Repligen 's latest financial reports the company's total assets are HK$22.75 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$21.96 B-0.65%
2023-12-31HK$22.11 B11.79%
2022-12-31HK$19.78 B7.56%
2021-12-31HK$18.38 B24.66%
2020-12-31HK$14.75 B35.28%
2019-12-31HK$10.90 B79.76%
2018-12-31HK$6.06 B4.42%
2017-12-31HK$5.80 B159.29%
2016-12-31HK$2.24 B97.66%
2015-12-31HK$1.13 B13.9%
2014-12-31HK$0.99 B8.16%
2013-12-31HK$0.92 B22.35%
2012-12-31HK$0.75 B
2011-03-31HK$0.56 B1.38%
2010-03-31HK$0.55 B-2.96%
2009-03-31HK$0.57 B6.7%
2008-03-31HK$0.53 B135.8%
2007-03-31HK$0.22 B1.95%
2006-03-31HK$0.22 B3.54%
2005-03-31HK$0.21 B-6.66%
2004-03-31HK$0.23 B10.33%
2003-03-31HK$0.20 B-7.97%
2002-03-31HK$0.22 B-9.43%
2001-03-31HK$0.25 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
HK$9.18 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$59.27 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$33.20 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$998.29 B 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$801.94 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.22 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.624 T 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$19.66 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.69 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$58.49 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA